PL3956323T3 - Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowych - Google Patents
Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowychInfo
- Publication number
- PL3956323T3 PL3956323T3 PL19724354.6T PL19724354T PL3956323T3 PL 3956323 T3 PL3956323 T3 PL 3956323T3 PL 19724354 T PL19724354 T PL 19724354T PL 3956323 T3 PL3956323 T3 PL 3956323T3
- Authority
- PL
- Poland
- Prior art keywords
- oxazole
- agonists
- fatty acid
- free fatty
- acid receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/060211 WO2020211956A1 (en) | 2019-04-18 | 2019-04-18 | Oxazole and oxadiazole derivatives useful as agonists of free fatty acid receptor 1 |
| EP19724354.6A EP3956323B1 (en) | 2019-04-18 | 2019-04-18 | Oxazole and oxadiazole derivatives useful as agonists of free fatty acid receptor 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3956323T3 true PL3956323T3 (pl) | 2025-06-23 |
Family
ID=66554320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19724354.6T PL3956323T3 (pl) | 2019-04-18 | 2019-04-18 | Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowych |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220274968A1 (pl) |
| EP (1) | EP3956323B1 (pl) |
| ES (1) | ES3028253T3 (pl) |
| PL (1) | PL3956323T3 (pl) |
| WO (1) | WO2020211956A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3956323T3 (pl) * | 2019-04-18 | 2025-06-23 | Halo Therapeutics Ltd | Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowych |
| AU2020472970A1 (en) * | 2020-10-20 | 2023-06-22 | Halo Therapeutics Ltd | Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor |
| CN113214242B (zh) * | 2021-04-23 | 2022-09-20 | 中国药科大学 | 一种母核为3-苯基-1，2，4-噁二唑的化合物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040006011A1 (en) * | 1996-07-12 | 2004-01-08 | Gour Barbara J. | Peptidomimetic modulators of cell adhesion |
| PL3956323T3 (pl) * | 2019-04-18 | 2025-06-23 | Halo Therapeutics Ltd | Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowych |
-
2019
- 2019-04-18 PL PL19724354.6T patent/PL3956323T3/pl unknown
- 2019-04-18 US US17/604,718 patent/US20220274968A1/en active Pending
- 2019-04-18 WO PCT/EP2019/060211 patent/WO2020211956A1/en not_active Ceased
- 2019-04-18 EP EP19724354.6A patent/EP3956323B1/en active Active
- 2019-04-18 ES ES19724354T patent/ES3028253T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20220274968A1 (en) | 2022-09-01 |
| EP3956323C0 (en) | 2025-03-05 |
| EP3956323A1 (en) | 2022-02-23 |
| WO2020211956A1 (en) | 2020-10-22 |
| EP3956323B1 (en) | 2025-03-05 |
| ES3028253T3 (en) | 2025-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3956323T3 (pl) | Pochodne oksazolu i oksadiazolu przydatne jako agoniści receptora 1 wolnych kwasów tłuszczowych | |
| IL286566A (en) | A process for the preparation of microbiocidal derivatives of oxadiazole | |
| SG11202102431YA (en) | Organoid compositions for the production of hematopoietic stem cells and derivatives thereof | |
| EP3856173A4 (en) | TREATMENT OF HEMATOLOGICAL MALIGNITIES WITH MENIN INHIBITORS | |
| IL265803A (en) | Isoxazole analogs as fxr agonists and methods of use thereof | |
| PL3911647T3 (pl) | Związek izoksazolowy jako agonista fxr oraz zawierające go kompozycje farmaceutyczne | |
| BR112017003421A2 (pt) | formas sólidas cristalinas de 6-carbóxi-2-(3,5-diclorofenil)-benzoxazol | |
| NZ740727A (en) | Phenyl derivatives as cannabinoid receptor 2 agonists | |
| MX2022006823A (es) | Derivados de isoxazol como agonistas del receptor nuclear y usos de los mismos. | |
| IL288901A (en) | Combined treatment of liver diseases using fxr agonists | |
| BR112017006425B8 (pt) | Compostos derivados de isoxazol, seus usos, inibidores de isocitrato desidrogenase 1 mutante e da produção de d-2 hidroxiglutamato, agente antitumoral e composição farmacêutica compreendendo os mesmos | |
| PT3737470T (pt) | Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40 | |
| ES3063485T3 (en) | Compositions and methods of using itaconic acid derivatives | |
| IL317999A (en) | Oxazole TRPML1 agonists and their uses | |
| IL283964A (en) | History of testosterone active ester, preparations and their uses | |
| EP3952852A4 (en) | PROPHYLACTIC EFFECTIVENESS OF SEROTONIN-4 RECEPTOR AGONISTS AGAINST STRESS | |
| EP3736280A4 (en) | SWEETENING COMPOSITION AND MANUFACTURING METHOD AND USE THEREOF | |
| EP3744711A4 (en) | METHOD FOR MANUFACTURING MESACONIN AND RELATED INTERMEDIATE PRODUCTS | |
| EP3719020A4 (en) | CRYSTALLINE FORM OF SS LACTAMASE INHIBITOR AND MANUFACTURING METHOD FOR IT | |
| GB2571997B (en) | Use of wafer brightness to monitor laser anneal process and laser anneal tool | |
| EP4076671A4 (en) | NOVEL MEDICINAL PRODUCTS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERTHEMATOSUS (SLE) AND METHODS OF DIAGNOSIS AND TREATMENT USING THE SAME | |
| EP3723727A4 (en) | PHARMACEUTICAL COMPOSITIONS OF FLURBIPROFEN AND 5-HT1 RECEPTORAGONISTS | |
| EP3348546A4 (en) | CRYSTALLINE FORM OF AN ANDROGEN RECEPTOR HEATHER AND METHOD OF MANUFACTURING THEREOF | |
| ZA202100484B (en) | Crystal of benzoxazole derivative | |
| ZA202100513B (en) | Isoxazole as fxr receptor agonists |